Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009 (2009), Article ID 579407, 3 pages
http://dx.doi.org/10.1155/2009/579407
Case Report

Rapid Fatal Outcome from Pulmonary Arteries Compression in Transitional Cell Carcinoma

Department of Medical Oncology, University Hospital of Larissa, Larissa 41110, Greece

Received 13 July 2009; Accepted 1 October 2009

Academic Editor: Thomas R. Chauncey

Copyright © 2009 Ioannis A. Voutsadakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Decousus, N. Moulin, S. Quenet et al., “Thrombophilia and risk of venous thrombosis in patients with cancer,” Thrombosis Research, vol. 120, supplement 2, pp. S51–S61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Babu and T. L. Carman, “Cancer and clots: all cases of venous thromboembolism are not treated the same,” Cleveland Clinic Journal of Medicine, vol. 76, no. 2, pp. 129–135, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. L. D. Wilson, F. C. Detterbeck, and J. Yahalom, “Superior vena cava syndrome with malignant causes,” The New England Journal of Medicine, vol. 356, no. 18, pp. 1862–1869, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. V. F. Tapson, “Acute pulmonary embolism,” The New England Journal of Medicine, vol. 358, no. 10, pp. 1037–1052, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. C. K. Chan, M. A. Hutcheon, R. H. Hyland, G. J. Smith, B. J. Patterson, and R. A. Matthay, “Pulmonary tumor embolism: a critical review of clinical, imaging, and hemodynamic features,” Journal of Thoracic Imaging, vol. 2, no. 4, pp. 4–14, 1987. View at Google Scholar · View at Scopus
  6. R. H. Winterbauer, I. B. Elfenbein, and W. C. Ball Jr., “Incidence and clinical significance of tumor embolization to the lungs,” The American Journal of Medicine, vol. 45, no. 2, pp. 271–290, 1968. View at Google Scholar · View at Scopus
  7. S. S. Dhillon, D. Singh, B. Dass, and C. R. Schaub, “Transitional cell carcinoma manifesting as acute cor pulmonale: cause of microscopic tumor embolism,” Southern Medical Journal, vol. 94, no. 10, pp. 1030–1032, 2001. View at Google Scholar · View at Scopus
  8. D. Han, K. S. Lee, T. Franquet et al., “Thrombotic and nonthrombotic pulmonary arterial embolism: spectrum of imaging findings,” Radiographics, vol. 23, no. 6, pp. 1521–1539, 2003. View at Google Scholar · View at Scopus
  9. M. Remy-Jardin, J. Remy, L. Wattinne, and F. Giraud, “Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique—comparison with pulmonary angiography,” Radiology, vol. 185, no. 2, pp. 381–387, 1992. View at Google Scholar · View at Scopus
  10. T. K. B. Teo, S. K. Venkatesh, L. K. A. Tan, and P. S. Wong, “Small cell neuroendocrine carcinoma presenting as a pulmonary artery mass,” Clinical Radiology, vol. 62, no. 10, pp. 1015–1018, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. C. J. Bischoff and P. E. Clark, “Bladder cancer,” Current Opinion in Oncology, vol. 21, no. 3, pp. 272–277, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Ono, M. Ozawa, K. Suzuki et al., “Autopsy findings of patients with urological neoplasms,” International Journal of Clinical Oncology, vol. 7, no. 5, pp. 301–305, 2002. View at Google Scholar · View at Scopus
  13. S. M. Goldman, A. A. Fajardo, R. C. Naraval, and J. E. Madewell, “Metastatic transitional cell carcinoma from the bladder: radiographic manifestations,” American Journal of Roentgenology, vol. 132, no. 3, pp. 419–425, 1979. View at Google Scholar · View at Scopus
  14. C. Locher, J. Auroux, C. Locher, C. Copie-Bergman, and J.-C. Delchier, “Médiastinite carcinomateuse secondaire à un carcinome vésical,” Presse Medicale, vol. 34, no. 19, pp. 1373–1374, 2005. View at Google Scholar · View at Scopus
  15. B. E. Nicholson, H. F. Frierson, M. R. Conaway et al., “Profiling the evolution of human metastatic bladder cancer,” Cancer Research, vol. 64, no. 21, pp. 7813–7821, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. R. V. Iaffaioli, A. Milano, and F. Caponigro, “Therapy of metastatic bladder carcinoma,” Annals of Oncology, vol. 18, supplement 6, pp. vi153–vi156, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. Von der Maase, S. W. Hansen, J. T. Roberts et al., “Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study,” Journal of Clinical Oncology, vol. 18, no. 17, pp. 3068–3077, 2000. View at Google Scholar · View at Scopus
  18. S. Culine, C. Theodore, M. De Santis et al., “A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen,” British Journal of Cancer, vol. 94, no. 10, pp. 1395–1401, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus